Capricor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.
CAPR Key Statistics
Stock Snapshot
As of today, Capricor(CAPR) shares are valued at $10.05. The company's market cap stands at 586.33M, with a P/E ratio of -4.11.
On 2026-08-28, Capricor(CAPR) stock traded between a low of $10.01 and a high of $10.19. Shares are currently priced at $10.05, which is +0.4% above the low and -1.3% below the high.
The Capricor(CAPR)'s current trading volume is 53.13K, compared to an average daily volume of 18.09M.
In the last year, Capricor(CAPR) shares hit a 52-week high of $40.37 and a 52-week low of $2.96.
In the last year, Capricor(CAPR) shares hit a 52-week high of $40.37 and a 52-week low of $2.96.
CAPR News
...
H.C. Wainwright notes that Capricor Therapeutics (CAPR) announced that the FDA extended the PDUFA target action date for deramiocel from August 22 to November 2...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Analyst ratings
90%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.